147 related articles for article (PubMed ID: 31758450)
1. CRISPR/Cas9-Mediated Generation of Tetracycline Repressor-Based Inducible Knockdown in Toxoplasma gondii.
Jacot D; Soldati-Favre D
Methods Mol Biol; 2020; 2071():125-141. PubMed ID: 31758450
[TBL] [Abstract][Full Text] [Related]
2. Development of CRISPR/Cas9 for Efficient Genome Editing in Toxoplasma gondii.
Shen B; Brown K; Long S; Sibley LD
Methods Mol Biol; 2017; 1498():79-103. PubMed ID: 27709570
[TBL] [Abstract][Full Text] [Related]
3. QTL Mapping and CRISPR/Cas9 Editing to Identify a Drug Resistance Gene in Toxoplasma gondii.
Shen B; Powell RH; Behnke MS
J Vis Exp; 2017 Jun; (124):. PubMed ID: 28671645
[TBL] [Abstract][Full Text] [Related]
4. Efficient gene disruption in diverse strains of Toxoplasma gondii using CRISPR/CAS9.
Shen B; Brown KM; Lee TD; Sibley LD
mBio; 2014 May; 5(3):e01114-14. PubMed ID: 24825012
[TBL] [Abstract][Full Text] [Related]
5. New and emerging uses of CRISPR/Cas9 to genetically manipulate apicomplexan parasites.
Di Cristina M; Carruthers VB
Parasitology; 2018 Aug; 145(9):1119-1126. PubMed ID: 29463318
[TBL] [Abstract][Full Text] [Related]
6. Optimizing Systems for Cas9 Expression in Toxoplasma gondii.
Markus BM; Bell GW; Lorenzi HA; Lourido S
mSphere; 2019 Jun; 4(3):. PubMed ID: 31243081
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of the basic functions of six calcium-dependent protein kinases in Toxoplasma gondii using CRISPR-Cas9 system.
Wang JL; Huang SY; Li TT; Chen K; Ning HR; Zhu XQ
Parasitol Res; 2016 Feb; 115(2):697-702. PubMed ID: 26499803
[TBL] [Abstract][Full Text] [Related]
8. CRISPR/Cas9 and genetic screens in malaria parasites: small genomes, big impact.
Ishizaki T; Hernandez S; Paoletta MS; Sanderson T; Bushell ESC
Biochem Soc Trans; 2022 Jun; 50(3):1069-1079. PubMed ID: 35621119
[TBL] [Abstract][Full Text] [Related]
9. Efficient genome engineering of Toxoplasma gondii using CRISPR/Cas9.
Sidik SM; Hackett CG; Tran F; Westwood NJ; Lourido S
PLoS One; 2014; 9(6):e100450. PubMed ID: 24971596
[TBL] [Abstract][Full Text] [Related]
10. CRISPR-Cas9-based genome-wide screening of Toxoplasma gondii.
Sidik SM; Huet D; Lourido S
Nat Protoc; 2018 Jan; 13(1):307-323. PubMed ID: 29323662
[TBL] [Abstract][Full Text] [Related]
11. mSphere of Influence: Ushering in the CRISPR Revolution to
Guerra AJ
mSphere; 2019 Jul; 4(4):. PubMed ID: 31270169
[TBL] [Abstract][Full Text] [Related]
12. A CRISPR platform for targeted in vivo screens identifies Toxoplasma gondii virulence factors in mice.
Young J; Dominicus C; Wagener J; Butterworth S; Ye X; Kelly G; Ordan M; Saunders B; Instrell R; Howell M; Stewart A; Treeck M
Nat Commun; 2019 Sep; 10(1):3963. PubMed ID: 31481656
[TBL] [Abstract][Full Text] [Related]
13. Inducible in vivo genome editing with CRISPR-Cas9.
Dow LE; Fisher J; O'Rourke KP; Muley A; Kastenhuber ER; Livshits G; Tschaharganeh DF; Socci ND; Lowe SW
Nat Biotechnol; 2015 Apr; 33(4):390-394. PubMed ID: 25690852
[TBL] [Abstract][Full Text] [Related]
14. Application of the CRISPR/Cas9 gene editing technique to research on functional genomes of parasites.
Cui Y; Yu L
Parasitol Int; 2016 Dec; 65(6 Pt A):641-644. PubMed ID: 27586395
[TBL] [Abstract][Full Text] [Related]
15. Toxoplasma CRISPR/Cas9 constructs are functional for gene disruption in Neospora caninum.
Arranz-Solís D; Regidor-Cerrillo J; Lourido S; Ortega-Mora LM; Saeij JPJ
Int J Parasitol; 2018 Jul; 48(8):597-600. PubMed ID: 29625127
[TBL] [Abstract][Full Text] [Related]
16. Functional Characterization of Dense Granule Proteins in
Bai MJ; Wang JL; Elsheikha HM; Liang QL; Chen K; Nie LB; Zhu XQ
Front Cell Infect Microbiol; 2018; 8():300. PubMed ID: 30211128
[TBL] [Abstract][Full Text] [Related]
17. Knockout of leucine aminopeptidase in Toxoplasma gondii using CRISPR/Cas9.
Zheng J; Jia H; Zheng Y
Int J Parasitol; 2015 Feb; 45(2-3):141-8. PubMed ID: 25444863
[TBL] [Abstract][Full Text] [Related]
18. A CRISPR upgrade unlocks Toxoplasma gene function.
Tsee Dawson A; Tonkin CJ
Trends Parasitol; 2022 Oct; 38(10):826-828. PubMed ID: 35973902
[TBL] [Abstract][Full Text] [Related]
19. Efficient editing of malaria parasite genome using the CRISPR/Cas9 system.
Zhang C; Xiao B; Jiang Y; Zhao Y; Li Z; Gao H; Ling Y; Wei J; Li S; Lu M; Su XZ; Cui H; Yuan J
mBio; 2014 Jul; 5(4):e01414-14. PubMed ID: 24987097
[TBL] [Abstract][Full Text] [Related]
20. A Genome-wide CRISPR Screen in Toxoplasma Identifies Essential Apicomplexan Genes.
Sidik SM; Huet D; Ganesan SM; Huynh MH; Wang T; Nasamu AS; Thiru P; Saeij JPJ; Carruthers VB; Niles JC; Lourido S
Cell; 2016 Sep; 166(6):1423-1435.e12. PubMed ID: 27594426
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
